PopulationsHumans
URINARY INCONTINENCE IN US ADULTS WITH DIABETES WHO ARE GUIDELINE-RECOMMENDED TO RECEIVE SGLT2IS: NHANES 2013–2020
GSA 2024 Abstract
Abstract
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are now recommended as first-line cardiorenal protective therapy for many adults with type 2 diabetes but are also associated with increased risk of urogenital infections.